1. Home
  2. KREF vs ETON Comparison

KREF vs ETON Comparison

Compare KREF & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KKR Real Estate Finance Trust Inc.

KREF

KKR Real Estate Finance Trust Inc.

N/A

Current Price

$6.78

Market Cap

437.7M

Sector

Real Estate

ML Signal

N/A

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

N/A

Current Price

$18.41

Market Cap

411.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KREF
ETON
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
437.7M
411.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
KREF
ETON
Price
$6.78
$18.41
Analyst Decision
Buy
Strong Buy
Analyst Count
6
3
Target Price
$9.80
$31.00
AVG Volume (30 Days)
1.2M
294.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
14.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,011,000.00
Revenue This Year
$560.38
$107.23
Revenue Next Year
$0.36
$29.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.29
52 Week Low
$6.64
$11.09
52 Week High
$11.53
$23.00

Technical Indicators

Market Signals
Indicator
KREF
ETON
Relative Strength Index (RSI) 36.27 62.21
Support Level $6.64 $16.04
Resistance Level $9.42 $20.01
Average True Range (ATR) 0.21 1.03
MACD 0.02 0.01
Stochastic Oscillator 20.11 55.28

Price Performance

Historical Comparison
KREF
ETON

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Share on Social Networks: